Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1494	CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conferen	bob zagorin	-	4/24/2003
1493	CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conferen	bob zagorin	-	4/24/2003
1492	<<I'm guessing Velcade will generate revenue of about $10K/patient x 2	Miljenko Zuanic	-	4/24/2003
1491	Constructive chart action the last few days. Been a long time since it was over	Area51	-	4/24/2003
1490	Aventis ending the 3-5 year, $160M-$200M deal after 3 years and $160M is not a s	microcapfun	-	4/23/2003
1489	<i> At this point I will not bet an solid cancer potential, but hematology	microcapfun	-	4/23/2003
1488	Millennium Pharma: Got $160M Total Under Aventis Pact Tuesday April 22, 6:02 pm	SemiBull	-	4/22/2003
1487	April 22, 2003 MILLENNIUM PHARMACEUTICALS INC (MLNM) form 8-K Item 5. Other Even	Icebrg	-	4/22/2003
1486	i added to my mlnm today because i think the end of the uncertainly about the co	bob zagorin	-	4/21/2003
1485	At this point I will not bet an solid cancer potential, but hematology market is	Miljenko Zuanic	-	4/21/2003
1484	4 Opinions on IIb/IIIa Usage * Abciximab Started in the Cath Lab is Still the B	microcapfun	-	4/21/2003
1483	<I> FDA approval might be granted in Q3/03, leading to product launch by y	software salesperson	-	4/21/2003
1482	Goldman-Sachs take: <b>MLNM announced that it is no longer actively consi	PCSS	-	4/21/2003
1481	Millennium Confirms Terms of Convertible Notes CAMBRIDGE, Mass., Apr 21, 2003	bob zagorin	-	4/21/2003
1480	"The FDA cannot really say no unless there are some undisclosed and very ne	quidditch	-	4/20/2003
1479	>>Wondering what the likelihood is that Velcade will get the go ahead:>	Icebrg	-	4/20/2003
1478	If you're asking me specifically..... I'm leaning toward approval for	scaram(o)uche	-	4/19/2003
1477	Wondering what the likelihood is that Velcade will get the go ahead: healthcentr	Ron	-	4/19/2003
1476	<I>NEW YORK (Dow Jones)--Millennium Pharmaceuticals Inc. Chief Financial O	software salesperson	-	4/16/2003
1475	After UBS W downgrades MLNM to neutral this morning, here is GS's view (main	quidditch	-	4/16/2003
1474	MZ think your right eu approval is pobably earlier would however more like nova	dalroi	-	4/16/2003
1473	EU Partner? First, they are looking for best deal that will take care about nea	Miljenko Zuanic	-	4/15/2003
1472	<I> It was stated that there would be upfront funding associated with the	software salesperson	-	4/15/2003
1471	Thanks, sales. I am always a few days behind in listening at the cc's. Two	microcapfun	-	4/15/2003
1470	Now that we're not competing with MSFT and INTC for CCBN's bandwidth, th	Ian@SI	-	4/15/2003

Go to reply# or date (mm/dd/yy):